A multi-institutional team has recently sequenced the body louse genome, an achievement that will yield new insights into louse – and human – biology and evolution.
The body louse genome is the smallest known genome of any insect, said University of Illinois entomology professor Barry Pittendrigh, who led the drive to fund the project and coordinated the international team of scientists who analyzed the sequence.
Australian team member Dr. Stephen Cameron from CSIRO Entomology is researching the gene that is responsible for body lice responding to their environment.
“Lice have a simple life either in your hair or on your body with blood as their food. So most of the genes responsible for sensing their environment have been reduced,” Cameron said. “One gene in particular is responsible for normal cell maintenance and in the body louse this gene is missing. This can give valuable insights into diseases and human aging.”
The body louse’s pared-down list of detoxifying enzymes makes it an attractive organism for the study of resistance to insecticides or other types of chemical defense, Pittendrigh said. University of Illinois entomology professor and department head May Berenbaum and former graduate student Reed Johnson contributed to this effort.
The body louse is also known to transmit lethal diseases such as typhus whereas its close relative, the head louse, does not. This study is helping explain the differences between these two insects as to which genes are involved in transmitting disease.
Other work that the team was involved in included sequencing the genome of a microbe that lives in the body louse gut. This research revealed that the body louse is not just dependant on humans for survival but also a particular bacteria which aids in the production of an essential nutrient.
This will make the body louse a useful tool for understanding co-evolution of disease carrying parasites and their bacterial co-conspirators.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.